- September 26th, 2008Aridis awarded two advanced technology grants totaling more than $2MM to develop stabilization technologies for F. tularensis and filovirus vaccines. More..
- February 19th, 2008Aridis acquired exclusive rights to gallium based anti-infective compound (PanaecinTM).
- June 1st, 2007Aridis Awarded $2MM by PATH Vaccine Solutions. More..
- April 15, 2007Aridis awarded NIH STTR grant with Harvard U. for monoclonal antibody development. More..